Amgen Sues Sandoz Over Biosimilar Patent Talks
Amgen sued Sandoz on Friday in New Jersey federal court for trying to skip patent discussions related a biosimilar version of anti-infection blockbuster Neulasta, the latest legal fight over dueling interpretations of...To view the full article, register now.
Already a subscriber? Click here to view full article